Maharashtra, India

Sushrut Kulkarni

This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sushrut Kulkarni. Retrieved from https://idiyas.com/inventor/sushrut-kulkarni-x7egyymh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sushrut Kulkarni: Innovator in Respiratory Therapeutics

Introduction

Sushrut Kulkarni is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of respiratory therapeutics, particularly through his innovative work on metered dose inhalers.

Latest Patents

Kulkarni holds a patent for a metered dose inhaler that comprises a stable pharmaceutical composition of fluticasone or its pharmaceutically acceptable ester. This invention includes a canister fitted with a metering valve, an actuator, and a dose counter. The patent also details a process for preparing the pharmaceutical composition and its application in treating respiratory disorders such as asthma in subjects, including humans. He has 1 patent to his name.

Career Highlights

Sushrut Kulkarni is currently employed at Glenmark Pharmaceuticals Limited, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on creating effective solutions for respiratory health.

Collaborations

Kulkarni collaborates with talented professionals in his field, including Julianne Berry and Rajesh Ankam. Their combined expertise contributes to the innovative projects at Glenmark Pharmaceuticals.

Conclusion

Sushrut Kulkarni's contributions to respiratory therapeutics through his patented inventions highlight his role as a key innovator in the pharmaceutical industry. His work continues to impact the treatment of respiratory disorders, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…